PRO-LAD
From Wikipedia, the free encyclopedia
|
PRO-LAD
|
|
| Systematic (IUPAC) name | |
| (6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fg]quinoline-9-carboxamide |
|
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C22H29N3O |
| Mol. mass | 351.50 g/mol |
| Synonyms | PRO-LAD, 6-propyl-6-nor-Lysergic acid diethylamide |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Controlled in the US via the Federal Analog Act |
| Routes | Oral |
PRO-LAD, also known as 6-propyl-6-nor-lysergic acid diethylamide, is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PRO-LAD is a hallucinogenic drug similar to LSD, and is around as potent as LSD itself with an active dose reported at between 100 and 200 micrograms.
PRO-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
[edit] External links
|
|||||
|
|||||

